[1] Sumana BS, Sabaretnam M, Sarathi V.  Functional parathyroid cystic adenoma: A rare cause of hypercalcemic crisis with primary hyperparathyroidism[J]. Indian J Pathol Microbiol, 2015, 58(4): 487-490.   doi: 10.4103/0377-4929.168847
[2] 邹珍, 常娅妮, 崔雅丽, 等.  巨大甲状旁腺腺瘤99Tcm-MIBI双时相SPECT/CT显像一例[J]. 国际放射医学核医学杂志, 2017, 41(2): 156-158.   doi: 10.3760/cma.j.issn.1673-4114.207.02.014
Zou Z, Chang YN, Cui YL, et al.  99Tcm-MIBI dual-phase SPECT/CT imaging of giant parathyroid adenoma: case report[J]. Int J Radiat Med Nucl Med, 2017, 41(2): 156-158.   doi: 10.3760/cma.j.issn.1673-4114.207.02.014
[3] Park JH, Kang SW, Jeong JJ, et al.  Surgical treatment of tertiary hyperparathyroidism after renal transplantation: a 31-year experience in a single institution[J]. Endocrine J, 2011, 58(10): 827-833.   doi: 10.1507/endocrj.ej11-0053
[4] 张自立, 王金亮, 徐辉, 等.  尿毒症规律血液透析患者继发性及三发性甲状旁腺功能亢进症合并甲状腺癌三例报告[J]. 天津医药, 2017, 45(5): 522-525.   doi: 10.11958/20170022
Zhang ZL, Wang JL, Xu H, et al.  Three cases of thyroid carcinoma accompanied with secondary or tertiary hyperparathyroidism in uremia patients on maintenance hermodialysis[J]. Tianjin Med J, 2017, 45(5): 522-525.   doi: 10.11958/20170022
[5] Jamal SA, Miller PD.  Secondary and tertiary hyperparathyroidism[J]. J Clin Densitom, 2013, 16(1): 64-68.   doi: 10.1016/j.jocd.2012.11.012
[6] Thomas LF, McCarthy JT, Wenger DE, et al.  Digital manifestations of tertiary hyperparathyroidism[J]. Kidney Int, 2012, 82(6): 724-.   doi: 10.1038/ki.2012.128
[7] Cocchiara G, Fazzotta S, Palumbo VD, et al.  The medical and surgical treatment in secondary and tertiary hyperparathyroidism. Review[J]. Clin Ter, 2017, 168(2): e158-e167.   doi: 10.7417/CT.2017.1999
[8] García-Talavera P, Díaz-Soto G, Montes AA, et al.  Contribution of early SPECT/CT to 99mTc-MIBI double phase scintigraphy in primary hyperparathyroidism: Diagnostic value and correlation between uptake and biological parameters[J]. Rev Esp Med Nucl Imagen Mol, 2016, 35(6): 351-357.   doi: 10.1016/j.remn.2016.03.001
[9] Kedarisetty S, Fundakowski C, Ramakrishnan K, et al.  Clinical value of 99mTc-MIBI SPECT/CT versus 4D-CT or US in management of patients with hyperparathyroidism[J]. Ear Nose Throat J, 2019, 98(3): 149-157.   doi: 10.1177/0145561319828668
[10] Dulfer RR, Franssen GJH, Hesselink DA, et al.  Systematic review of surgical and medical treatment for tertiary hyperparathyroidism[J]. Br J Surg, 2017, 104(7): 804-813.   doi: 10.1002/bjs.10554
[11] 钟箫, 欧晓红, 李林, 等.  99Tcm-MIBI SPECT/CT融合显像在甲状旁腺功能亢进症术前诊断中的应用价值[J]. 中华核医学与分子影像杂志, 2017, 37(7): 395-399.   doi: 10.3760/cma.j.issn.2095-2848.2017.07.004
Zhong X, Ou XH, Li L, et al.  Value of 99Tcm-MIBI SPECT/CT in pre-operative diagnosis of primary and secondary hyperparathyroidism[J]. Chin J Nucl Med Mol Imaging, 2017, 37(7): 395-399.   doi: 10.3760/cma.j.issn.2095-2848.2017.07.004
[12] Ozkan ZG, Unal SN, Kuyumcu S, et al.  Clinical Utility of Tc-99m MIBI SPECT/CT for preoperative localization of parathyroid lesions[J]. Indian J Surg, 2017, 79(4): 312-318.   doi: 10.1007/s12262-016-1489-7